Search for low allergenic apple cultivars for birch pollen-allergic patients

Allerg Immunol (Paris). 2006 Mar;38(3):94-8.

Search for low allergenic apple cultivars for birch pollen-allergic patients: is there a correlation between in vitro a says and patient response?

Asero R, Marzban G, Martinelli A, Zaccarini M, Machado ML. Ambulatorio di Allergologia, Clinica San Carlo, Paderno Dugnano, MI, Italy.

BACKGROUND: Due to the cross-reactivity between Bet v 1 and proteins present in vegetable foods, birch pollen allergic patients frequently develop allergy to fruits and vegetables, mostly apples. Since many apple cultivars exist some of them might contain sufficiently low amounts of Mal d 1 to be tolerated by most allergic patients. OBJECTIVE: To assess whether apple cultivars containing low amounts of Mal d 1 are better tolerated by apple-allergic patients. METHODS: Mal d 1 content was determined in many apple cultivars by ELISA. Selected cultivars containing high (Golden Delicious) or low (Orim, G 198 and Vienna) amounts of Mal d 1 were compared in apple allergic patients both by SPT and oral challenges. RESULTS: The 3 different apple cultivars induced wheals of similar size in most patients. Upon oral challenges no patient reported the total absence of oral symptoms following the ingestion of either high or low allergenic apples. Golden Delicious and G-198 elicited OAS of similar severity 3/7 cases. The 2 cultivars induced significantly more severe symptoms in 2 cases each. CONCLUSION: Allergy to Mal d 1 is characterized by significant inter-patient variability. Moreover, marked inter-apple and intra-apple variability exists. As a consequence, the amount of Mal d 1 in apples classified as containing low concentrations of allergen may be sufficient to induce both clinical symptoms and skin reactivity in birch pollen-allergic patients. The search for low allergenic apples therefore should be continued and extended to other germplasm accessions, be it cultivars, breeding lines or wild species.

PMID: 16752695 [PubMed - in process]

{mosgoogle}

{mos_sb_discuss:13}

Set as favorite

Bookmark

Email this

Comments (0) Add Comment